Consumer medicine information

DermAid 1% solution

Hydrocortisone 1 % w/w


Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about DermAid 1% solution.

It does not contain all the available information.

It does not take the place of talking to your doctor or pharmacist.

If you have any concerns about this medicine, ask your doctor or pharmacist.

Keep this leaflet with your medicine. You may need to read it again.

What is DermAid 1% solution used for?

The name of your medicine is DermAid 1% solution. It contains the active ingredient hydrocortisone at 1% w/w as the active ingredient.

Hydrocortisone belongs to the group of medicines called corticosteroids.

DermAid 1% solution is used for temporary relief of minor skin irritations, itching and rashes due to:

  • eczema
  • dermatitis
  • cosmetics and jewellery
  • insect bites
  • psoriasis
  • itching genital and anal areas
  • sunburn
  • other corticosteroid responsive conditions

Your doctor or pharmacist, however, may have prescribed DermAid 1% solution for another purpose.

Before using DermAid 1% solution

When you must not use this product

Do not use DermAid 1% solution if you have ever had an allergic reaction to:

  • hydrocortisone
  • any other corticosteroid
  • any of the other ingredients in DermAid 1% solution listed at the end of this leaflet.

Do not use DermAid 1% solution in the eyes.

Do not use DermAid 1% solution if you have:

  • a viral skin infection (such as cold sores, shingles or chicken pox, vaccinia, varicella)
  • a fungal skin infection (such as thrush, tinea or ringworm)
  • a bacterial skin infection (such as impetigo or boils)
  • tuberculous condition of the skin
  • syphilic type of skin disorders
  • acne

unless advised to by your doctor or pharmacist.

Precautions

DermAid 1% solution reduces inflammation and itching. As a result, signs of infection may be masked. The area being treated should be kept clean at all times. If there is a possibility of infection in the area being treated then the infection should be controlled first.

If irritation or sensitivity occurs discontinue use immediately and seek medical advice.

Be careful not to get DermAid 1% solution in your eyes. If this happens rinse your eyes with clean water. If irritation persists tell your doctor or pharmacist.

Do not use under waterproof bandages unless specified by your doctor.

Interactions

Although there are no generally recognised drug interactions attributed to hydrocortisone you should tell your doctor or pharmacist if you are using any other medicine.

Pregnancy and lactation

You must tell your doctor if you are pregnant or breast-feeding. Your doctor will tell you if you can use DermAid 1% solution during pregnancy or while you are breast-feeding.

Use in Children

Do not use DermAid 1% solution on children under 2 years of age without the advice of a doctor or pharmacist.

How to use DermAid 1% solution

Directions

DermAid 1% solution is for external use only.

Apply a few drops to the affected area 2-3 times daily. Massage in gently.

Your doctor or pharmacist may have recommended a different dosage. It is important to use DermAid 1% solution exactly as directed. If you use it less often than you should, it may not work as well and your skin problem may not improve. Using it more often than you should may not improve your skin problem any faster and may cause or increase side effects.

How long to use it

If your condition persists for more than 7 days then discontinue use and see your doctor or pharmacist.

If you forget to use it

If you forget to use DermAid 1% solution, use it as soon as you remember and then go back to your normal times for applying DermAid 1% solution. Do not try to make up for the amount you missed by using more than you would normally use.

Side effects

DermAid 1% solution helps most people with skin problems but it may have unwanted side effects in a few people. After the application of DermAid 1% solution a slight stinging sensation may occasionally be noticed. This transient symptom is most likely to disappear after several applications.

Side effects that have been reported by some people using cortisones include:

  • burning
  • itching
  • dryness
  • redness
  • allergy
  • thinning of the skin
  • blurred vision or other vision disturbances

If you have these or any other side effects, check with your doctor or pharmacist.

Do not be alarmed by this list of possible side effects. You may not experience any of them.

In case of overdose

If you have accidentally applied too much DermAid 1% solution, then wipe off any excess. Use DermAid 1% solution exactly as directed. If you use it more often than directed your skin problem may not improve any faster and you may cause or increase side effects. If you experience any side effects contact your doctor or pharmacist.

If you swallow it

Telephone your Poisons Information Centre (13 11 26 in Australia or 0800 764 766 in New Zealand) or contact your doctor or pharmacist.

Storage

Keep DermAid 1% solution where young children cannot reach it. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Keep DermAid 1% solution in a cool dry place where the temperature stays below 30°C. Do not leave DermAid 1% solution in the car or on windowsills. Heat can reduce the efficacy of some medicines.

Shelf life

Do not use DermAid 1% solution after the expiry date printed on the pack. If you use it after the expiry date has passed, it may not work as well.

Product description

DermAid 1% solution is a clear lotion packed in a 30mL dropper bottle.

DermAid 1% solution contains:

  • Hydrocortisone
  • Purified water
  • Hexylene glycol
  • Phenoxyethanol
  • Citric acid

For further information

This is not all the information that is available on DermAid 1% solution.

If you have any questions or are not sure about anything, ask your doctor or pharmacist.

Manufacturer

Ego Pharmaceuticals Pty. Ltd.
21-31 Malcolm Road, Braeside 3195
Australia.

Australian Registration number:
AUST R 260373

Date of last revision: June 2019

Published by MIMS September 2019